Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone

By R. Sackstein, Jasmeen S. Merzaban, D. Cain, N. Dagia, J. Spencer, Charles P. Lin, Roland Wohlgemuth. Nature Medicine, 2008

635 citations recorded by the source corpus.

Subfields: Cell Biology, Genetics, Immunology and Allergy

View Paper: https://www.semanticscholar.org/paper/a3719858c2c5cc95301af260246c2f6297d3bec9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. T. Suda

Citations in the corpus

• Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow (2009, background): “…and adipose tissue in vivo Although the transplantation of mesenchymal stem cells has not been believed to be feasible (Wang et al., 2005; Sackstein et al., 2008), we and several other groups have reported that freshly isolated BM cells can replace a part of mesenchymal or stromal cells…”
• Mammalian glycosylation in immunity (2008, neutral): “Glycan remodelling of the mesenchymal stem-cell surface in vitro to express selectin ligands increased cell tropism for the bone marrow after transplantation and resulted in increased bone formatio”